Assess whether the carve-out is operable on day one (6fb261)

SITUATION After a Phase II that found groundwater impact, management-team retention and key-person map is what buy-side QoE lead can touch in a health-system acquiring a specialty practice. M&A Due Diligence will live with Proceed versus Reprice on this Legal, IP, and Regulatory file.

DECISION Buy-side QoE lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using management-team retention and key-person map after a Phase II that found groundwater impact.

HYPOTHESES TO TEST 1. Authorize Proceed now; management-team retention and key-person map already has the discriminator after a Phase II that found groundwater impact. 2. Keep Reprice in force until management-team retention and key-person map is completed after a Phase II that found groundwater impact for buy-side QoE lead. 3. Treat management-team retention and key-person map as Walk because both readings appear after a Phase II that found groundwater impact. 4. Refuse a M&A Due Diligence close: buy-side QoE lead does not have the decision the carve-out is operable turns on in management-team retention and key-person map.

ANALYSIS REQUIRED 1. Separate a one-off add-back from a recurring earnings issue in management-team retention and key-person map. 2. Map reps, earnout mechanics, and integration risk a health-system acquiring a specialty practice would inherit. 3. Tie quality-of-earnings, working-capital, and contingent items in management-team retention and key-person map to the carve-out is operable. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read management-team retention and key-person map against a Phase II that found groundwater impact and write the one fact that would move the carve-out is operable for buy-side QoE lead.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (management-team retention and key-person map after a Phase II that found groundwater impact). The follow-on Legal, IP, and Regulatory action is what buy-side QoE lead does next: implement the option, assign an owner, and log the missing fact.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on the carve-out is operable, then the evidence in management-team retention and key-person map, then the action for buy-side QoE lead - Hypothesis scorecard against management-team retention and key-person map: supported / rejected / untestable - Owner and next date for buy-side QoE lead in a health-system acquiring a specialty practice - What changes the carve-out is operable if a Phase II that found groundwater impact is later withdrawn